Search research articles
Contact Us
Filters
Showing results (41-50 of 151) with videos related to
Page
of 16
Sort By:
The American Journal of Physiology
|
August 1, 1983
Blood pressure maintenance in awake dehydrated rats: renin, vasopressin, and sympathetic activity
M Burnier, J Biollaz, D B Brunner, et al.
Hypertension (Dallas, Tex. : 1979)
|
January 1, 1995
Characterization of the angiotensin II receptor antagonist TCV-116 in healthy volunteers
E Delacrétaz, J Nussberger, J Biollaz, et al.
Intensive Care Medicine
|
January 1, 1988
Hemofiltration clearance of flecainide in a patient with acute renal failure
A Borgeat, J Biollaz, B Freymond, et al.
Transplantation Proceedings
|
June 19, 2001
A preliminary evaluation of the discriminative power of the monoethylglycinexylidide formation test after intravenous and oral administration of lidocaine
J M Corpataux, A Munafo, T Buclin, et al.
Therapeutic Drug Monitoring
|
July 31, 2001
Nelfinavir plasma levels under twice-daily and three-times-daily regimens: high interpatient and low intrapatient variability
C Marzolini, T Buclin, L A Decosterd, et al.
Clinical Pharmacology and Therapeutics
|
July 1, 1986
Enprostil, in contrast to cimetidine, does not inhibit propranolol metabolism
C S Reilly, J Biollaz, R P Koshakji, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
October 29, 2000
Pharmacokinetics and pharmacodynamics of IFN-beta 1a in healthy volunteers
P A Buchwalder, T Buclin, I Trinchard, et al.
The American Journal of Medicine
|
August 1, 1992
Selective loss of optic nerve beta-tubulin in vincristine-induced blindness
F Munier, E Perentes, C P Herbort, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 1, 1982
Escape from mineralocorticoid excess: the role of angiotensin II
J Biollaz, J Dürr, H R Brunner, et al.
Journal of Cardiovascular Pharmacology
|
November 1, 1982
Antihypertensive therapy with MK 421: angiotensin II--renin relationships to evaluate efficacy of converting enzyme blockade
J Biollaz, H R Brunner, I Gavras, et al.
Page
of 16
Search research articles
Search
Showing results (41-50 of 151) with videos related to
Sort By:
Page
of 16
The American Journal of Physiology
|
August 1, 1983
Blood pressure maintenance in awake dehydrated rats: renin, vasopressin, and sympathetic activity
M Burnier, J Biollaz, D B Brunner, et al.
Hypertension (Dallas, Tex. : 1979)
|
January 1, 1995
Characterization of the angiotensin II receptor antagonist TCV-116 in healthy volunteers
E Delacrétaz, J Nussberger, J Biollaz, et al.
Intensive Care Medicine
|
January 1, 1988
Hemofiltration clearance of flecainide in a patient with acute renal failure
A Borgeat, J Biollaz, B Freymond, et al.
Transplantation Proceedings
|
June 19, 2001
A preliminary evaluation of the discriminative power of the monoethylglycinexylidide formation test after intravenous and oral administration of lidocaine
J M Corpataux, A Munafo, T Buclin, et al.
Therapeutic Drug Monitoring
|
July 31, 2001
Nelfinavir plasma levels under twice-daily and three-times-daily regimens: high interpatient and low intrapatient variability
C Marzolini, T Buclin, L A Decosterd, et al.
Clinical Pharmacology and Therapeutics
|
July 1, 1986
Enprostil, in contrast to cimetidine, does not inhibit propranolol metabolism
C S Reilly, J Biollaz, R P Koshakji, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
October 29, 2000
Pharmacokinetics and pharmacodynamics of IFN-beta 1a in healthy volunteers
P A Buchwalder, T Buclin, I Trinchard, et al.
The American Journal of Medicine
|
August 1, 1992
Selective loss of optic nerve beta-tubulin in vincristine-induced blindness
F Munier, E Perentes, C P Herbort, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 1, 1982
Escape from mineralocorticoid excess: the role of angiotensin II
J Biollaz, J Dürr, H R Brunner, et al.
Journal of Cardiovascular Pharmacology
|
November 1, 1982
Antihypertensive therapy with MK 421: angiotensin II--renin relationships to evaluate efficacy of converting enzyme blockade
J Biollaz, H R Brunner, I Gavras, et al.
Page
of 16